| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Virax Holdings Ltd (ASX: VHL)
VHL Technical Analysis
5
| As on 12th Dec 2014 VHL Share Price closed @ 0.14 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.01 & Strong Buy for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VHL Share Price
| Open | 0.14 | Change | Price | % |
| High | 0.14 | 1 Day | 0.00 | 0.00 |
| Low | 0.14 | 1 Week | 0.00 | 0.00 |
| Close | 0.14 | 1 Month | 0.00 | 0.00 |
| Volume | 22950 | 1 Year | 0.00 | 0.00 |
| 52 Week High 1.60 | 52 Week Low 1.48 | ||||
ASX Australia Most Active Stocks
| COE | 0.30 | 3.45% |
| GPP | 0.02 | 0.00% |
| DUE | 3.02 | 1.00% |
| BUR | 0.02 | 0.00% |
| AGO | 0.02 | 0.00% |
| BPT | 1.05 | 7.14% |
| PNX | 0.01 | 0.00% |
| PIO | 0.03 | 0.00% |
| DJS | 3.99 | 0.00% |
| KSO | 0.40 | 3900.00% |
ASX Australia Top Gainers Stocks
ASX Australia Top Losers Stocks
| VHL Daily Charts |
VHL Intraday Charts |
Whats New @ Bazaartrend |
VHL Free Analysis |
|
|
VHL Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.14 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
VHL Target for Month August
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
VHL Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
VHL Target for Year 2020
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
Virax Holdings Ltd ( ASX Australia Symbol : VHL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VHL Business Profile
Virax Holdings Limited, a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer in Australia. It primarily develops immunotherapeutics based on its Co-X-Gene and fowlpox virus delivery technologies. The companyÂ’s Co-X-Gene based vaccines are used for the treatment of HIV, hepatitis B virus, and prostate cancer. Its lead product includes VIR201, an HIV/AIDS immunotherapeutic product, which has completed two Phase I/IIa clinical trials. The company also develops VIR501, a therapeutic prostate cancer vaccine; and therapeutic human papilloma virus (HPV) vaccine. In addition, it licenses its technology to produce immunotherapeutic products, including TG4001, a cancer vaccine that has completed Phase IIb CIN2/3/HPV trial; and TG4010, a lung cancer vaccine, which has completed Phase IIb trial. Virax Holdings Limited is based in Kew, Australia.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
